Principal Investigators

    A/Pr Julie Atkin


    Macquarie University

    Contact information of lead PI



    Title of project or programme

    Cellular transport dysfunction and motor neuron disease

    Source of funding information

    National Health and Medical Research Council

    Total sum awarded (Euro)

    € 291,217

    Start date of award


    Total duration of award in years



    Research Abstract

    Amyotrophic lateral sclerosis (ALS) patients currently face a bleak future. In the common global form of disease, the average length of survival after diagnosis is 31 months. Current therapies have at best a modest effect on the course of the disease with little or no benefit in terms of overall patient survival. This study will address the basic underlying biochemical mechanisms of disease in both sporadic and genetic forms of ALS. This studies will lead to opportunities to develop new therapies in the future.

    Further information available at:

Types: Investments < €500k
Member States: Australia
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF